SCHEMBL13525199

SCHEMBL13525199

CC1=CC(=Nc2ccc(N)cc2)C(C)=CC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 1/20 0.41
▸ MAPT P10636 7/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ LMNA P02545 2/20 0.39
▸ S1PR2 O95136 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ XBP1 P17861 1/20 0.39
▸ MPI P34949 1/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ OPRD1 P41143 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ PLK1 P53350 2/20 0.37
▸ PLK2 Q9NYY3 2/20 0.37
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24514478 0.88 PABPC1 (0.37) PABPC1MAPTRAB9ALMNAS1PR2
SCHEMBL10782928 0.88 PABPC1 (0.41) PABPC1MAPTRAB9AALDH1A1MEN1
SCHEMBL24443643 0.88 PABPC1 (0.37) PABPC1MAPTRAB9ALMNAS1PR2
SCHEMBL24443875 0.85 PABPC1 (0.44) PABPC1MAPTRAB9ALMNAS1PR2
SCHEMBL11787610 0.82 PABPC1 (0.41) PABPC1MAPTRAB9ALMNAS1PR2
SCHEMBL11309468 0.79 PABPC1 (0.67) PABPC1MAPTRAB9ALMNAS1PR2
SCHEMBL11305871 0.78 PABPC1 (0.34) PABPC1MAPTRAB9APLK1PLK2
SCHEMBL10784128 0.78 NPC1 (0.36) PABPC1MAPTRAB9ALMNAALDH1A1
SCHEMBL11835602 0.77 CASP1 (0.36) MAPTRAB9ALMNAS1PR2ALDH1A1
SCHEMBL13525222 0.76 PABPC1 (0.36) PABPC1MAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645304-B2 Dyeing of in particular human keratin materials by dry thermal transfer of a direct azomethine dye, composition comprising the said dye and its method of preparation L'OREAL S.A. (FR) 2010-01-12 — — US disclosed
US-7645304-B2 Dyeing of in particular human keratin materials by dry thermal transfer of a direct azomethine dye, composition comprising the said dye and its method of preparation L'OREAL S.A. (FR) 2010-01-12 — — US disclosed
US-20080120792-A1 Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Azomethine Dye, Composition Comprising the Said Dye and its Method of Preparation L'OREAL S.A. (FR) 2008-05-29 — — US disclosed
US-20080120792-A1 Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Azomethine Dye, Composition Comprising the Said Dye and its Method of Preparation L'OREAL S.A. (FR) 2008-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080120792-A1 Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Azomethine Dye, Composition Comprising the Said Dye and its Method of Preparation KRT18, IK, KLK5 PABPC1 3727/4885MAPT 245/4885RAB9A 3116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback